J0480 Injection, basiliximab, 20 mg
Billable / valid for submission HCPCS Release 2026Q3
Short description: Basiliximab
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Injection, basiliximab, 20 mg | yes |
Related codes in J04
- J0400 Injection, aripiprazole, intramuscular, 0.25 mg
- J0401 Injection, aripiprazole (abilify maintena), 1 mg
- J0402 Injection, aripiprazole (abilify asimtufii), 1 mg
- J0456 Injection, azithromycin, 500 mg
- J0457 Injection, aztreonam, 100 mg
- J0458 Injection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg)
- J0461 Injection, atropine sulfate, 0.01 mg
- J0462 Injection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mg
- J0463 Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg
- J0470 Injection, dimercaprol, per 100 mg
- J0475 Injection, baclofen, 10 mg
- J0476 Injection, baclofen, 50 mcg for intrathecal trial
- J0485 Injection, belatacept, 1 mg
- J0490 Injection, belimumab, 10 mg
- J0491 Injection, anifrolumab-fnia, 1 mg